MARKET

ARMP

ARMP

Armata Pharmctcl
AMEX
1.190
-0.060
-4.80%
Opening 12:36 04/08 EDT
OPEN
1.310
PREV CLOSE
1.250
HIGH
1.310
LOW
1.180
VOLUME
13.91K
TURNOVER
--
52 WEEK HIGH
3.850
52 WEEK LOW
1.150
MARKET CAP
43.06M
P/E (TTM)
-2.2749
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ARMP last week (0331-0404)?
Weekly Report · 1d ago
Weekly Report: what happened at ARMP last week (0324-0328)?
Weekly Report · 03/31 10:05
Weekly Report: what happened at ARMP last week (0317-0321)?
Weekly Report · 03/24 09:59
Armata Pharmaceuticals: Promising Clinical Trials and Strong Financial Position Justify Buy Rating
TipRanks · 03/21 13:35
Armata Pharmaceuticals GAAP EPS of -$0.23, revenue of $1.2M
Seeking Alpha · 03/21 05:12
Armata Pharmaceuticals reports Q4 EPS (23c) vs (55c) last year
TipRanks · 03/20 22:00
*Armata Pharmaceuticals 4Q Rev $1.2M >ARMP
Dow Jones · 03/20 21:58
Press Release: Armata Pharmaceuticals Announces -2-
Dow Jones · 03/20 21:56
More
About ARMP
More
Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its bacteriophage-based technology. The Company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. It is advancing two lead candidates, such as AP-PA02 and AP-SA02, to address both chronic and acute bacterial infections. Its lead phage candidate, inhaled AP-PA02, is focused primarily on the treatment of chronic pulmonary infections due to Pseudomonas aeruginosa. In parallel, it has an acute bacterial infection clinical development plan focused on Staphylococcus aureus bacteremia, a difficult-to-treat and often life-threatening infection.
Recently
Symbol
Price
%Change

Webull offers Armata Pharmaceuticals Inc stock information, including AMEX: ARMP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARMP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARMP stock methods without spending real money on the virtual paper trading platform.